Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-047549
Filing Date
2018-08-17
Accepted
2018-08-17 20:29:55
Documents
1
Period of Report
2018-08-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6054
  Complete submission text file 0001209191-18-047549.txt   7633
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Issuer) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ARCADIA BIOSCIENCES, INC. 202 COUSTEAU PLACE, SUITE 105 DAVIS CA 95618
Business Address
O'Neil Thomas P. (Reporting) CIK: 0001640645 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37852 | Film No.: 181026911